scholarly article | Q13442814 |
P50 | author | Michael Hennerici | Q103148821 |
P2093 | author name string | Stephen Meairs | |
Peter Bugert | |||
Marc Fatar | |||
Björn Reuter | |||
Saskia Grudzenski | |||
Claus Rodemer | |||
P2860 | cites work | Multiple roles for MMPs and TIMPs in cerebral ischemia | Q36104645 |
Matrix metalloproteinases in cerebrovascular diseases | Q36222712 | ||
Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. | Q38071519 | ||
Temporal profile of matrix metalloproteinases and their inhibitors in a human endothelial cell culture model of cerebral ischemia | Q39132066 | ||
Blood-brain barrier-specific properties of a human adult brain endothelial cell line | Q40377619 | ||
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. | Q43234063 | ||
Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. | Q43278301 | ||
Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages | Q44381124 | ||
Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells | Q45774346 | ||
Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. | Q48825219 | ||
Simvastatin could prevent increase of the serum MMP-9/TIMP-1 ratio in acute ischaemic stroke | Q79447127 | ||
Markers of instability in high-risk carotid plaques are reduced by statins | Q80759664 | ||
P433 | issue | 2 | |
P921 | main subject | simvastatin | Q670131 |
P304 | page(s) | 156-159 | |
P577 | publication date | 2014-12-05 | |
P1433 | published in | Translational stroke research | Q26842494 |
P1476 | title | Effect of simvastatin on MMPs and TIMPs in human brain endothelial cells and experimental stroke | |
P478 | volume | 6 |
Q50052994 | Association of SNPs in the TIMP-2 gene and large artery atherosclerotic stroke in southern Chinese Han population |
Q47910464 | Blood-brain barrier dysfunction and recovery after ischemic stroke |
Q89289786 | Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection |
Q52147983 | Cyclooxygenase-2 Inhibition Provides Lasting Protection Following Germinal Matrix Hemorrhage in Premature Infant Rats. |
Q38592449 | Factors controlling permeability of the blood-brain barrier |
Q51007468 | Hyperbaric Oxygen Reduces Infarction Volume and Hemorrhagic Transformation Through ATP/NAD+/Sirt1 Pathway in Hyperglycemic Middle Cerebral Artery Occlusion Rats. |
Q48165537 | Iptakalim protects against ischemic injury by improving neurovascular unit function in the mouse brain |
Q40491247 | Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial. |
Q36244982 | Models and mechanisms of vascular dementia |
Q39143724 | Molecular hydrogen: a therapeutic antioxidant and beyond |
Q37576181 | Neuroprotective effect of hyperbaric oxygen therapy in a juvenile rat model of repetitive mild traumatic brain injury |
Q37576186 | Paradigms and mechanisms of inhalational anesthetics mediated neuroprotection against cerebral ischemic stroke. |
Q44836823 | Recent Advances in Stem Cell-Based Therapeutics for Stroke |
Q48337519 | Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke |
Q36512688 | Statin Therapy and the Development of Cerebral Amyloid Angiopathy--A Rodent in Vivo Approach |
Q52583601 | The Role of IRE1 Signaling in Central Nervous System Diseases. |
Q38969718 | The impact of cerebrovascular aging on vascular cognitive impairment and dementia. |
Q42368544 | The production of high dose hydrogen gas by the AMS-H-01 for treatment of disease |
Q36731242 | Translational Stroke Research on Blood-Brain Barrier Damage: Challenges, Perspectives, and Goals. |
Q28078744 | Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke |
Q36926500 | Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury |
Q38374295 | Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients. |
Q30959630 | What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment |
Search more.